All eyes are on Eastman Chemical Company (EMN), given that institutional investors hold close to 88% ownership. The stock has experienced fluctuations with TriaGen Wealth Management enhancing their stake while Bank of America has downgraded the company. Mixed performance indicators abound with EMN declaring a Q2 2024 dividend amid cost actions and innovation issues while grappling with demand woes. Analysts seem mixed with some seeing little upside due to current valuations while others believe the shares could be undervalued by 33%. In the last year, shareholders enjoyed a 57% return. Amid these developments, EMN is about to go ex-dividend. Its price target was raised to $118.00 by analysts at Wells Fargo & Company. Its debt levels have raised eyebrows; despite this, the share price rose by 14% over three months due to a significant drop in short interest. Strong fundamentals seem to be driving recent stock performance. In spite of layoffs at the Indian Orchard plant, optimistic shareholders from five years ago have seen a 77% return. Looking forward, Eastman CEO Mark Costa and Eastman CFO Willie McLain are both scheduled to address different conferences.
Eastman Chemical Company EMN News Analytics from Sat, 08 Aug 2020 18:08:52 GMT to Sat, 19 Oct 2024 15:58:46 GMT - Rating 0 - Innovation 5 - Information 3 - Rumor -2
